ATHE
Income statement / Annual
Last year (2024), Alterity Therapeutics Limited's total revenue was $4.02 M,
an increase of 2.63% from the previous year.
In 2024, Alterity Therapeutics Limited's net income was -$19.12 M.
See Alterity Therapeutics Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$4.02 M
|
$3.92 M
|
$5.12 M
|
$4.34 M
|
$0.00
|
$108,538.00
|
$201,174.00
|
$132,396.00
|
$142,657.00
|
$176,842.00
|
| Cost of Revenue |
$214,304.00 |
$285,067.00 |
$364,665.00 |
$360,026.00 |
$112,427.00 |
$29,696.00 |
$21,799.00 |
$21,328.00 |
$22,810.00 |
$257,299.00 |
| Gross Profit |
$3.80 M |
$3.63 M |
$4.76 M |
$3.98 M |
-$112,427.00 |
$78,842.00 |
$179,375.00 |
$111,068.00 |
$119,847.00 |
-$80,457.00 |
| Gross Profit Ratio |
0.95 |
0.93 |
0.93 |
0.92 |
0 |
0.73 |
0.89 |
0.84 |
0.84 |
-0.45 |
| Research and Development
Expenses |
$18.64 M
|
$13.20 M
|
$14.75 M
|
$12.28 M
|
$10.10 M
|
$12.98 M
|
$6.70 M
|
$5.70 M
|
$9.59 M
|
$12.30 M
|
| General & Administrative
Expenses |
$4.77 M
|
$4.99 M
|
$5.43 M
|
$6.85 M
|
$3.33 M
|
$4.28 M
|
$4.32 M
|
$3.95 M
|
$3.59 M
|
$4.06 M
|
| Selling & Marketing
Expenses |
-$9,674.00
|
$51,484.00
|
$79,329.00
|
$21,812.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$87,851.00
|
| Selling, General &
Administrative Expenses |
$4.76 M
|
$5.04 M
|
$5.51 M
|
$6.87 M
|
$3.33 M
|
$4.28 M
|
$4.32 M
|
$3.95 M
|
$3.59 M
|
$4.15 M
|
| Other Expenses |
$0.00 |
-$282,964.00 |
-$364,665.00 |
-$360,026.00 |
-$3.36 M |
-$4.79 M |
$2.90 M |
-$241,892.00 |
-$241,954.00 |
-$170,977.00 |
| Operating Expenses |
$23.41 M |
$17.35 M |
$17.54 M |
$19.31 M |
$10.07 M |
$12.47 M |
$11.10 M |
$6.77 M |
$8.49 M |
$10.61 M |
| Cost And Expenses |
$23.62 M |
$17.63 M |
$17.90 M |
$19.67 M |
$10.07 M |
$12.47 M |
$11.10 M |
$6.77 M |
$8.49 M |
$10.61 M |
| Interest Income |
$268,419.00 |
$16,436.00 |
$2,504.00 |
$20,676.00 |
$17,117.00 |
$108,538.00 |
$201,174.00 |
$132,396.00 |
$142,657.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$147,529.00
|
$102,263.00
|
$54,214.00
|
$75,369.00
|
$112,427.00
|
$29,696.00
|
$21,799.00
|
$21,328.00
|
$22,810.00
|
$31,587.00
|
| EBITDA |
-$19.57 M
|
-$17.51 M
|
-$17.39 M
|
-$19.36 M
|
-$13.34 M
|
-$12.77 M
|
-$11.37 M
|
-$6.86 M
|
-$8.56 M
|
-$10.57 M
|
| EBITDA Ratio |
-4.87 |
-3.73 |
-3.02 |
-3.49 |
0 |
-116.86 |
-52.71 |
-45 |
-64.35 |
-59.8 |
| Operating Income Ratio
|
-4.88
|
-3.74
|
-3.03
|
-3.5
|
0
|
-117.14
|
-38.62
|
-51.98
|
-60.19
|
-59.01
|
| Total Other
Income/Expenses Net |
$524,333.00
|
$904,682.00
|
$2.72 M
|
-$133,036.00
|
$428,684.00
|
$324,637.00
|
-$127,858.00
|
-$786,284.00
|
$811,971.00
|
$4.68 M
|
| Income Before Tax |
-$19.08 M |
-$13.70 M |
-$12.78 M |
-$15.31 M |
-$10.06 M |
-$12.34 M |
-$8.27 M |
-$7.54 M |
-$7.73 M |
-$5.89 M |
| Income Before Tax Ratio
|
-4.75
|
-3.5
|
-2.49
|
-3.53
|
0
|
-113.67
|
-41.09
|
-56.97
|
-54.18
|
-33.28
|
| Income Tax Expense |
$46,088.00 |
$104,459.00 |
$70,008.00 |
-$4.13 M |
-$362,188.00 |
-$376,031.00 |
-$495,440.00 |
$660,213.00 |
-$857,248.00 |
-$170,977.00 |
| Net Income |
-$19.12 M |
-$13.81 M |
-$12.85 M |
-$15.31 M |
-$9.70 M |
-$11.96 M |
-$8.27 M |
-$7.54 M |
-$7.73 M |
-$5.89 M |
| Net Income Ratio |
-4.76 |
-3.53 |
-2.51 |
-3.53 |
0 |
-110.21 |
-41.09 |
-56.97 |
-54.18 |
-33.28 |
| EPS |
-0.0052 |
-0.0057 |
-0.0053 |
-0.009 |
-0.0108 |
-0.0194 |
-0.0155 |
-0.0141 |
-0.0145 |
-0.0117 |
| EPS Diluted |
-0.0052 |
-0.0057 |
-0.0053 |
-0.009 |
-0.0108 |
-0.0194 |
-0.0155 |
-0.0141 |
-0.0145 |
-0.0117 |
| Weighted Average Shares
Out |
$3.65 B
|
$2.43 B
|
$2.41 B
|
$1.70 B
|
$894.87 M
|
$615.77 M
|
$533.27 M
|
$533.89 M
|
$533.11 M
|
$502.71 M
|
| Weighted Average Shares
Out Diluted |
$3.65 B
|
$2.43 B
|
$2.41 B
|
$1.70 B
|
$894.87 M
|
$615.77 M
|
$533.89 M
|
$533.89 M
|
$533.89 M
|
$502.71 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
